Alendronate 70 mg once weekly vs. placebo: Tolerability study in patients with osteoporosis.

被引：0
作者：
Greenspan, SL
Field-Munves, EM
Tonino, RP
Mako, B
Smith, ME
Yates, J
Palmisano, J
机构：
[1] Oteoporosis Prevent & Treatment Ctr, Pittsburgh, PA USA
[2] Springhouse Profess Ctr, Allentown, PA USA
[3] Good Hlth, Burlington, VT USA
[4] Merck & Co Inc, W Point, PA USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2001年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S405 / S405
页数：1
相关论文
共 50 条
  • [1] Alendronate 70 mg once weekly vs. placebo: Tolerability study in patients with osteoporosis.
    Palmisano, J
    Melton, M
    Greenspan, SL
    Field-Munves, EM
    Tonino, RP
    Dinh, AC
    Smith, ME
    Wang, L
    Keene, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S24 - S24
  • [2] Alendronate 70 mg once weekly Vs. placebo: Tolerability study in patients with osteoporosis
    Palmisano, J
    Melton, M
    Greenspan, SL
    Field-Munves, EM
    Tonino, RP
    Dinh, AC
    Smith, ME
    Wang, L
    Keene, W
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S27 - S27
  • [3] Alendronate 70 mg once weekly versus placebo: Tolerability study in patients with osteoporosis
    Palmisano, J
    Greenspan, SL
    Field-Munves, EM
    Tonino, RP
    Dinh, A
    Smith, ME
    Wang, L
    Thompson, D
    Yates, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S43 - S43
  • [4] Alendronate 70 mg once weekly versus placebo: Tolerability study in patients with osteoporosis
    Field-Munves, E
    Greenspan, S
    Tonino, R
    Robbins, J
    Einhorn, D
    Dinh, A
    Smith, B
    Wang, LX
    Palmisano, J
    GASTROENTEROLOGY, 2002, 122 (04) : A474 - A474
  • [5] Efficacy, safety and tolerability of once weekly (80 mg vs. 160 mg) oral alendronate in postmenopausal osteoporosis.
    Brown, JP
    Banville, C
    Jean, S
    Drake, WM
    Kendler, DL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S528 - S528
  • [6] Assessment of upper gi tolerability of alendronate (fosamax) 70 mg once weekly vs. placebo
    Eisman, J
    Rizzoli, R
    Gaines, KA
    Verbruggen, N
    Melton, ME
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S42 - S42
  • [7] Alendronate 70 mg Once Weekly and alendronate 10 mg Once Daily preference study in postmenopausal women with osteoporosis.
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, M
    Wang, L
    Yates, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S404 - S404
  • [8] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis.
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, ME
    Wang, L
    Yates, J
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S64 - S64
  • [9] Upper GI tolerability of alendronate (FOSAMAX) 70 mg once weekly is similar to placebo.
    Eisman, J
    Rizzoli, R
    Gaines, KA
    Verbruggen, N
    Melton, ME
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S474 - S474
  • [10] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, ME
    Wang, L
    Thompson, D
    Yates, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S43 - S44
12345